| Sep 27 |
Bristol Myers Stock Up on FDA Nod for Schizophrenia Treatment
|
| Sep 27 |
Dow, S&P 500 Rise at Open; Chinese Indexes Post Best Week in Years
|
| Sep 27 |
Bristol-Myers Stock Gains on FDA Approval for New Schizophrenia Drug
|
| Sep 27 |
14 Stocks Gain Momentum As August Inflation Comes In Below Expectations
|
| Sep 27 |
Bristol-Myers Squibb Gets FDA Approval for Schizophrenia Drug
|
| Sep 27 |
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
|
| Sep 27 |
Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking.
|
| Sep 27 |
These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava Sciences, Trump Media, HP Inc., and More
|
| Sep 27 |
Bristol-Myers Squibb stock gains on FDA approval of schizophrenia treatment
|
| Sep 27 |
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb's Cobenfy As First New Class Of Treatment In More Than 3 Decades
|
